SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $63,000 | +250.0% | 5,618 | +246.4% | 0.00% | – |
| Q2 2017 | $18,000 | +12.5% | 1,622 | +1.4% | 0.00% | – |
| Q1 2017 | $16,000 | -61.0% | 1,600 | -58.2% | 0.00% | – |
| Q4 2016 | $41,000 | +156.2% | 3,832 | +136.1% | 0.00% | – |
| Q3 2016 | $16,000 | -27.3% | 1,623 | -4.5% | 0.00% | – |
| Q2 2016 | $22,000 | -8.3% | 1,700 | -22.7% | 0.00% | – |
| Q1 2016 | $24,000 | -91.9% | 2,200 | -93.2% | 0.00% | – |
| Q4 2015 | $297,000 | +1385.0% | 32,285 | +981.9% | 0.00% | – |
| Q3 2015 | $20,000 | -95.9% | 2,984 | -94.0% | 0.00% | – |
| Q2 2015 | $487,000 | +14.1% | 49,679 | +3.2% | 0.00% | – |
| Q1 2015 | $427,000 | +2568.8% | 48,147 | +2574.8% | 0.00% | – |
| Q4 2014 | $16,000 | +14.3% | 1,800 | -10.0% | 0.00% | – |
| Q3 2014 | $14,000 | -22.2% | 2,000 | -42.9% | 0.00% | – |
| Q2 2014 | $18,000 | +63.6% | 3,500 | +40.0% | 0.00% | – |
| Q1 2014 | $11,000 | +120.0% | 2,500 | +150.0% | 0.00% | – |
| Q4 2013 | $5,000 | -95.2% | 1,000 | -95.2% | 0.00% | – |
| Q3 2013 | $105,000 | +1650.0% | 20,688 | +1508.7% | 0.00% | – |
| Q2 2013 | $6,000 | – | 1,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |